ID   HyCyte B-CPAP stable cell line for hSLC5A5 overexpression
AC   CVCL_F4QG
SY   B-CPAP stable cell line for hSLC5A5 overexpression
DR   Hysigen; CGSC-M31151
CC   Population: Caucasian.
CC   Characteristics: Transduced with pLV[Exp]-CMV>hSLC5A5[NM_000453.3]-EF1A>GFP:T2A:Puro-WPRE.
CC   Doubling time: 24-36 hours (Hysigen=CGSC-M31151).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259Tyr (c.775G>T); ClinVar=VCV000634680; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; EGFP.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C6040; Poorly differentiated thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0153 ! B-CPAP
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 25-06-26; Last updated: 25-06-26; Version: 1
//